NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL)
- PMID: 11205254
NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL)
Abstract
Background: Immune cells express TNF-related apoptosis-inducing ligand (TRAIL) and may play an important role in controlling the growth of renal cancer. For this reason we examined the potential cytotoxic and intracellular signaling effects of TRAIL on several renal cancer cell (RCC) lines.
Methods: Cytotoxicity was determined using an MTS tetrazolium based assay. Death receptor expression was measured by reverse-transcription polymerase chain reaction. Immunoblot analysis was used to measure cFLIP, caspase-8 and phosphorylated JNK and p38. Activation of NF-kappa B was determined by electrophoretic mobility shift assays.
Results: Two RCC lines were highly sensitive to TRAIL-induced cell death, two were of intermediate sensitivity, and two were insensitive. Sensitivity to TRAIL-stimulated apoptosis did not correlate with expression of death receptors, decoy receptors, or expression of the caspase-8-inhibitory protein cFLIP. Neither activation or inhibition of the NF-kappa B signal transduction pathway protected sensitive cells from TRAIL-induced cell death.
Conclusions: NF-kappa B, although stimulated in these cell lines, does not play a role in the sensitivity of RCC to TRAIL and could play other functions in TRAIL signaling.
Similar articles
-
Mechanisms of resistance to TRAIL-induced apoptosis in cancer.Cancer Gene Ther. 2005 Mar;12(3):228-37. doi: 10.1038/sj.cgt.7700792. Cancer Gene Ther. 2005. PMID: 15550937 Review.
-
Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.Cancer Res. 2003 Mar 1;63(5):1059-66. Cancer Res. 2003. PMID: 12615723
-
Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.Cancer Res. 2002 Aug 1;62(15):4180-5. Cancer Res. 2002. PMID: 12154014
-
Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells.Gynecol Oncol. 2004 Jun;93(3):594-604. doi: 10.1016/j.ygyno.2004.03.029. Gynecol Oncol. 2004. PMID: 15196850
-
Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors.Vitam Horm. 2004;67:453-83. doi: 10.1016/S0083-6729(04)67023-3. Vitam Horm. 2004. PMID: 15110190 Review.
Cited by
-
Pathway analysis of kidney cancer using proteomics and metabolic profiling.Mol Cancer. 2006 Nov 24;5:64. doi: 10.1186/1476-4598-5-64. Mol Cancer. 2006. PMID: 17123452 Free PMC article.
-
Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage.Br J Cancer. 2003 Jun 2;88(11):1800-7. doi: 10.1038/sj.bjc.6600984. Br J Cancer. 2003. PMID: 12771998 Free PMC article.
-
Up-regulation of the DR5 expression by proteasome inhibitor MG132 augments TRAIL-induced apoptosis in soft tissue sarcoma cell lines.Cancer Res Treat. 2011 Jun;43(2):124-30. doi: 10.4143/crt.2011.43.2.124. Epub 2011 Jun 30. Cancer Res Treat. 2011. PMID: 21811429 Free PMC article.
-
Combining proteasome inhibition with TNF-related apoptosis-inducing ligand (Apo2L/TRAIL) for cancer therapy.Cancer Immunol Immunother. 2006 Jan;55(1):76-84. doi: 10.1007/s00262-005-0676-3. Epub 2005 Oct 27. Cancer Immunol Immunother. 2006. PMID: 15864587 Free PMC article. Review.
-
Bortezomib enhances antigen-specific cytotoxic T cell responses against immune-resistant cancer cells generated by STAT3-ablated dendritic cells.Pharmacol Res. 2013 May;71:23-33. doi: 10.1016/j.phrs.2013.02.001. Epub 2013 Feb 18. Pharmacol Res. 2013. PMID: 23428347 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials
Miscellaneous